Yamamoto Ryo, Nakayama Masaaki, Hasegawa Toshio, Miwako Numata, Yamamoto Hiroyasu, Yokoyami Keitaro, Ikeda Masato, Kato Naohiko, Hayakawa Hiroshi, Takahashi Hajime, Otsuka Yasushi, Kawaguchi Yoshindo, Hosoya Tastuo
Division of Kidney and Hypertension, Jikei University School of Medicine, Tokyo, Japan.
Adv Perit Dial. 2002;18:131-4.
Increased peritoneal function has been suggested to be a risk factor for developing encapsulating peritoneal sclerosis (EPS); however, clinical evidence is scarce. The present study aimed to clarify the specific character of peritoneal function in patients who developed EPS after withdrawal from peritoneal dialysis (PD). We studied 12 patients who developed EPS after PD withdrawal [(EPS group) mean PD duration: 109 months; mean period of EPS development: 7.0 months after withdrawal] and 128 patients who did not develop EPS (non EPS group). All 140 patients were withdrawn from continuous ambulatory peritoneal dialysis (CAPD) and were observed for the following 24 months. Based on the records of the annual peritoneal equilibration tests (PETs), we analyzed (1) the patients' dialysate-to-plasma (D/P) creatinine at various durations on PD, and (2) the accumulative appearance incidence of high-transport (HT) state of peritoneal membrane. The mean D/P creatinine in EPS group was significantly higher than that in the non EPS group in the course of PD from the 6th to the 10th year. The accumulative incidence of HT was significantly higher in the EPS group than in the non EPS group, indicating early development of HT membrane in EPS group. Early development of increased D/P creatinine, classified as HT state, was observed during certain periods on PD in patients who developed EPS after PD withdrawal. That finding may indicate that HT state of peritoneal membrane is an early marker for EPS, and that the PET is useful to detect patients at high risk of EPS.
腹膜功能增强被认为是发生包裹性腹膜硬化(EPS)的一个危险因素;然而,临床证据却很匮乏。本研究旨在阐明腹膜透析(PD)撤机后发生EPS的患者腹膜功能的具体特征。我们研究了12例PD撤机后发生EPS的患者(EPS组,平均PD时间:109个月;EPS发生的平均时间:撤机后7.0个月)以及128例未发生EPS的患者(非EPS组)。所有140例患者均停止持续非卧床腹膜透析(CAPD),并在接下来的24个月进行观察。基于年度腹膜平衡试验(PET)记录,我们分析了(1)患者在PD不同时间段的透析液与血浆(D/P)肌酐比值,以及(2)腹膜高转运(HT)状态的累积出现发生率。在PD第6年至第10年期间,EPS组的平均D/P肌酐显著高于非EPS组。EPS组HT的累积发生率显著高于非EPS组,表明EPS组HT膜出现较早。在PD撤机后发生EPS的患者中,在PD的某些时间段观察到D/P肌酐升高(归类为HT状态)出现较早。这一发现可能表明腹膜HT状态是EPS的早期标志物,且PET有助于检测出EPS高危患者。